RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 April 2010

FDA and the European Medicines Agency recently agreed to accept the submission of a single annual report from sponsors of orphan drug and biologic products. The single annual report submission to both regulatory agencies is voluntary and will apply only to sponsors who have obtained an orphan designation status for their product from both FDA and the European Medicines Agency. Starting 28 February 2010, sponsors are allowed to send the single Orphan Drug Designation Annual Report to both agencies.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.